CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
8.71
+0.24 (2.83%)
Jul 2, 2026, 1:05 PM EDT - Market open
CorMedix Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 181.01 | 163.06 | -17.93 | -46.34 | -29.7 | -28.21 |
Depreciation & Amortization | 25.33 | 15.39 | 0.46 | 0.21 | 0.21 | 0.18 |
Stock-Based Compensation | 14.91 | 13.83 | 6.13 | 5.49 | 4.07 | 5.04 |
Other Adjustments | 4.22 | -24.49 | 0.14 | - | - | - |
Change in Receivables | -71.51 | -90.92 | -51.79 | - | 0.04 | -0.04 |
Changes in Inventories | -4.61 | -3.48 | -5.49 | -2.11 | 0 | 0.15 |
Changes in Accounts Payable | 8.06 | 3.33 | -2.56 | 2.08 | -0.01 | 1.08 |
Changes in Accrued Expenses | 53.27 | 100.77 | 22.99 | 3 | 0.96 | 0.09 |
Changes in Other Operating Activities | -2.54 | -2.43 | -2.55 | -0.74 | 0.07 | 0.56 |
Operating Cash Flow | 197.69 | 175.05 | -50.62 | -38.41 | -24.36 | -21.16 |
Capital Expenditures | -2.98 | -2.26 | -0.12 | -0.33 | -0.22 | -1.43 |
Purchases of Investments | -37.97 | -52.95 | -26.77 | -77.08 | -31.14 | -15.29 |
Proceeds from Sale of Investments | 49.19 | 55.29 | 48.12 | 60.35 | 27.65 | 7.58 |
Payments for Business Acquisitions | - | -308.51 | - | - | - | - |
Investing Cash Flow | -305.27 | -308.43 | 21.23 | -17.06 | -3.71 | -9.13 |
Long-Term Debt Issued | - | 150 | - | - | - | - |
Net Long-Term Debt Issued (Repaid) | - | 150 | - | - | - | - |
Issuance of Common Stock | 49.43 | 96.55 | 26.61 | 56.12 | 17.9 | 41.76 |
Repurchase of Common Stock | -13.59 | -1.99 | -0.29 | -0.2 | - | - |
Net Common Stock Issued (Repurchased) | 35.84 | 94.56 | 26.32 | 55.92 | 17.9 | 41.76 |
Other Financing Activities | - | -6.11 | - | - | - | - |
Financing Cash Flow | 220.26 | 238.45 | 26.32 | 55.92 | 17.9 | 41.76 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -0 | -0 | - | 0 | -0.01 | -0.01 |
Net Cash Flow | 112.68 | 105.07 | -3.07 | 0.45 | -10.18 | 11.45 |
Free Cash Flow | 194.71 | 172.79 | -50.73 | -38.74 | -24.58 | -22.58 |
Free Cash Flow Growth | 12.69% | - | - | - | - | - |
FCF Margin | 50.29% | 55.43% | -116.70% | - | -37573.50% | -11826.20% |
Free Cash Flow Per Share | 2.26 | 2.15 | -0.86 | -0.76 | -0.61 | -0.60 |
Levered Free Cash Flow | 257.55 | 424.37 | -5.21 | -44.23 | -28.69 | -27.58 |
Unlevered Free Cash Flow | 277.38 | 248.41 | -11.25 | -46.85 | -29.02 | -27.56 |